A delayed consent approach to informed consent used by researchers in a recent study comparing outcomes in ST-elevation myocardial infarction patients (STEMI) resulted in ethical concerns being voiced.
Direct-to-consumer genetic testing presents multiple ethical concerns, including individuals being given misleading or inaccurate information. In July 2014, the U.S. Food and Drug Administration announced coming draft guidelines for the regulation of laboratory developed tests.
Technology allows for preclinical detection of some brain disorders or conditions, but such testing also presents numerous ethical concerns.
Critically ill patients known wishes not to be resuscitated or placed on life support were ignored 60% of the time, according to a 2014 study mainly because of efforts by patients families to countermand their known wishes, and inability to locate documentation of patients wishes.
Advance directives and proxy opinions are equally effective in influencing doctors decisions, but having both has the strongest effect, says a 2014 study.
